March 11th, 2010 by Jonathan Foulds, Ph.D. in Better Health Network, News, Opinion
No Comments »
In the previous posting I discussed the possibility of FDA requiring that no tobacco products be allowed to emit Carbon Monoxide. While appealing in its simplicity, such a strategy may have problems in that it could be interpreted as a ban on a whole class (or classes) of tobacco products, which the legislation does not allow.
Another strategy might be to reduce the harm from tobacco by lowering the nicotine content/delivery of cigarettes down to the level at which they are no longer addictive. A form of this strategy was proposed in the 1990’s by leading tobacco researchers Professor Neal Benowitz, and Professor Jack Henningfield. The FDA legislation singles out nicotine as the only chemical that cannot be reduced to zero, but this allows FDA the right to reduce the nicotine delivery of tobacco products down to a level just above zero at which they would no longer be addictive. Read more »
This post, Will Nicotine-Free Cigarettes Be Mandated By The FDA?, was originally published on
Healthine.com by Jonathan Foulds, Ph.D..
March 10th, 2010 by Berci in Better Health Network, News
No Comments »
You have probably heard about the Food and Drug Administration Social Media Hearing that took place last November focusing on how FDA-regulated products should use internet and social media for health-related communications. It also has an own, properly designed, online presence including Twitter streams and partners.
A week ago, I had a chance to attend a lively discussion focusing on this issue in the virtual realm of Second Life moderated by Patricia F. Anderson. I’ve seen numerous conferences in Second Life and this one was again a nice example that virtual environment is still useful when people from around the world would like to gather around and watch a presentation, then discuss it. Read more »
*This blog post was originally published at ScienceRoll*
February 15th, 2010 by RyanDuBosar in Better Health Network, Health Policy, News
No Comments »
ACP Internist continues its look at subjects important to internal medicine. Today, we follow the money.
Evidence-based medicine
The U.S. could save one-third of the $15 billion spent on stents annually if all doctors followed COURAGE trial conclusions and used generic drugs first, and stents only if pain persists. William Boden, FACP, headed that trial, and now says that reimbursement drives clinical practice. Dartmouth’s Elliott Fisher, MD, says this “perverse incentive” doesn’t improve health care. (Wall Street Journal, CNN)
Physician reimbursement reform
Following the Food and Drug Administration’s record-breaking budget allocation, seven former agency commissioners and interest groups are still saying it’s not enough to make up for years of underfunding. Even regulated industries want more funding to boost the public perception of product safety. (ACP Internist, Los Angeles Times)
*This blog post was originally published at ACP Internist*
January 24th, 2010 by Peggy Polaneczky, M.D. in Better Health Network, News, True Stories
2 Comments »
Bayer Pharmaceuticals, the maker of the Mirena IUD, has teamed up with the Mommy marketing site “Mom Central” to sponsor house parties to sell women the Mirena IUD.
According to a warning letter sent to Bayer by the FDA about the worded content of the events –
The Mirena program is a live presentation designed for a consumer audience of “busy moms.” The program is presented in a consumer’s home or other private setting (e.g. private restaurant party) by a representative from Mom Central (a social networking internet site) and a nurse practitioner (Ms. Barb Dehn). The Mirena program submitted to FDA also references a presentation given by a fashion stylist (Ms. Angela Hastings) that immediately follows Ms. Dehn’s presentation regarding the use of Mirena. The script of Ms. Hastings’ presentation regarding fashion tips was not submitted to FDA.
The events start with an intro by a Mom Central rep – Read more »
*This blog post was originally published at The Blog that Ate Manhattan*
January 19th, 2010 by Jonathan Foulds, Ph.D. in Better Health Network, Health Tips, Opinion
No Comments »
The Wall Street Journal reported Jan. 6 that Philip Morris and U.S. Smokeless Tobacco Co., both parts of the Altria Group Inc., wrote to the FDA suggesting that tobacco products be ranked on their harmfulness to health. This would most likely result in smokeless tobacco products being ranked as markedly less harmful than cigarettes. Philip Morris apparently claimed the plan would have “a significant public-health benefit.” (assuming smokers took the rankings at face value and switched from more to less harmful products).
Now at face value, this sounds reasonably sensible. But when we consider that Philip Morris USA makes the vast majority of its profits from cigarette sales, and the plan would apparently reduce those sales as smokers switched to smokeless products, it is reasonable to wonder what they are playing at. Read more »
This post, Why Would Philip Morris Support Smokeless Tobacco Products? To Maintain Dependency On Nicotine?, was originally published on
Healthine.com by Jonathan Foulds, Ph.D..
